Navana Pharmaceuticals PLC announcements
122 Dhaka Stock Exchange announcements for Navana Pharmaceuticals PLC (NAVANAPHAR) since 2022: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (30).
- National Credit Ratings Limited has assigned surveillance entity rating of the Company as \"AA\" in the long term and \"
National Credit Ratings Limited has assigned surveillance entity rating of the Company as \"AA\" in the long term and \"ST-2\" in the short term along with a stable outlook based on audited financial statements as on June 30, 2023 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Resumption after Record date
Trading of the shares of the company will resume on 20.11.2023.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 19.11.2023.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 1.11 for July-September 2023 as against Tk. 0.91 for July-September 2022. NOCFPS was Tk. 1.19 for July-September 2023 as against Tk. 1.18 for July-September 2022. NAV per share was Tk. 41.73 as on September 30, 2023 and Tk. 40.71 as on June 30, 2023. Increase in Sales Revenue and efficient usages of material resulted in increased gross profit for the reporting period which resulted in the increment of EPS as well.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 15.11.2023 to 16.11.2023 and trading of the shares will remain suspended on record date i.e., 19.11.2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2023.
- The Board of Directors has recommended 13\% Cash Dividend for the year ended June 30, 2023. Date of AGM: 28.12.2023, Tim
The Board of Directors has recommended 13\% Cash Dividend for the year ended June 30, 2023. Date of AGM: 28.12.2023, Time: 4:00 PM, Venue: Digital Platform. Record Date: 19.11.2023. The Company has also reported EPS of Tk. 3.59, NAV per share of Tk. 40.71 and NOCFPS of Tk. 1.80 for the year ended June 30, 2023 as against Tk. 3.42, Tk. 43.41 and Tk. 2.48 respectively for the year ended June 30, 2022. (cont.)
- The company has requested the concerned brokerage houses and merchant bankers to provide with a statement with the detai
The company has requested the concerned brokerage houses and merchant bankers to provide with a statement with the details (shareholders name, BO ID number, e-TIN number, gross dividend receivable, applicable tax rate, and net dividend receivable) of their margin loan holders who hold shares of the Company as on the Record Date, along with the name of the contact person in this connection. (cont.)
- Dividend Declaration
(Continuation news of NAVANAPHAR): Reasons for deviation in NAVPS and NOCFPS: NAVPS has been decreased due to an increase in the number of ordinary shares of the company for the Initial Public Offerings (IPO) in comparison to the last year, the NAV per Share has decreased though the Net Asset Value increased. NOCFPS has been decreased due to an increase of paid-up share. (end)
The first part of this announcement is missing from the archive. - Update of Information
(Continuation news of NAVANAPHAR): The company has also requested the brokerage houses and merchant bankers to provide their Bank Account Name, Number, Routing number etc. on or before December 10, 2023. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (23.10.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 22, 2023 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.
- Board decision regarding investment in upcoming Digital Bank
The company has informed that the Board of Directors of the company has decided to invest BDT 7,50,00,000.00 in the proposed Digital Bank namely 'UPAY Digital Bank PLC' as a sponsor shareholder subject to receiving approval from the Regulatory Authorities. The proposed digital bank's initial paid-up capital is BDT 125.00 Crore wherein the company will subscribe 6% share of the proposed digital bank.
- National Credit Ratings Limited has assigned the Surveillance entity rating of the Company as \"AA\" in the long term an
National Credit Ratings Limited has assigned the Surveillance entity rating of the Company as \"AA\" in the long term and \"ST-2\" in the short term along with Stable outlook based on audited financial statements as on March 31, 2023.
- Shareholders' approval to change the Use of IPO Proceeds
Refer to their earlier news disseminated by DSE on 03.07.2023 regarding decision to change the Use of IPO Proceeds, the company has further informed that the shareholders in the 6th EGM of the company have approved to change the Use of Proceeds of IPO.
- Resumption after record date
Trading of the shares of the company will resume on 06.07.2023.
- Suspension for Record date
Trading of the shares of the company will be suspended on record date i.e., 05.07.2023 for EGM.
- The company has informed that the Board of Directors of the company has approved and recommended to change the Use of Pr
The company has informed that the Board of Directors of the company has approved and recommended to change the Use of Proceeds of IPO regarding Construction of new General Production Building, which constitutes Tk. 23.24 Cr. (31\%) of the total IPO proceeds of Tk. 75 Cr., and replace it with Modernization and Expansion of the small volume parenterals and ophthalmics (SVPO) Facility for Tk. 13.12 Cr. along with similar Modernization and Expansion of General Liquid Facility with (cont.1)
- (Continuation news of NAVANAPHAR): Dispensing Area for Tk. 4.68 Cr., Modernization and expansion of Animal Health Facili
(Continuation news of NAVANAPHAR): Dispensing Area for Tk. 4.68 Cr., Modernization and expansion of Animal Health Facility for Tk. 5.44 Cr. and modernization of PD & Quality Control for Tk. 2.34 Cr. (to be financed from company\'s own source) totaling Tk. 25.57 Cr. The Board resolved this after appropriate market assessment, and due to the delay in getting products to market after building the entirely new production facility, (cont.2)
The first part of this announcement is missing from the archive. - Decision to change the Use of IPO Proceeds
(Continuation news of NAVANAPHAR): and to immediately meet up the demand for the Company's products. The balance Use of Proceeds of the IPO remains the same, with 52% of the Use of Proceeds already completed. This is subject to obtaining approval from the shareholders of the Company in its upcoming 6th Extra Ordinary General Meeting scheduled to be held on July 31, 2023 and Bangladesh Securities and Exchange Commission (BSEC). (end)
The first part of this announcement is missing from the archive. - Spot for EGM
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 03.07.2023 to 04.07.2023, and trading of the shares will be suspended on record date i.e., 05.07.2023 for EGM.
- The company has informed that the Board of Directors has decided to issue an unsecured partially convertible and redeema
The company has informed that the Board of Directors has decided to issue an unsecured partially convertible and redeemable bond of TK. 150.00 crore (Taka One Fifty Crore) for 5 years through Private Offer in order to refinance the existing bank loan of the company subject to approval from the shareholders of the company in EGM, and Bangladesh Securities and Exchange commission. (cont.)
- EGM for issuance of unsecured partially convertible redeemable bond
(Continuation news of NAVANAPHAR): The coupon rate of this convertible bond shall be floating on semiannual basis. Date of EGM: 31.07.2023. Time: 12:00 Noon. Record date: 05.07.2023. Venue: Digital platform. (end)
The first part of this announcement is missing from the archive. - Query Response
In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike and increase in volume of shares.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 1.09 for Jan-March 2023 as against Tk. 0.85 for Jan-March 2022; EPS was Tk. 2.57 for July 2022-March 2023 as against Tk. 2.39 for July 2021-March 2022. NOCFPS was Tk. 2.85 for July 2022-March 2023 as against Tk. 2.13 for July 2021-March 2022. NAV per share was Tk. 40.90 as on March 31, 2023 and Tk. 43.41 as on March 31, 2022. (cont.)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 13, 2023 at 2:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.
- Q2 Financials
(Continuation news of NAVANAPHAR): Reasons for deviation in EPS and NOCFPS: Increase in Sales revenue and efficient usages of material resulted in increased gross profit for the reporting period. The reduced corporate tax rate for the period resulted in the increment of EPS as well. The growth in business volume and efficient utilization of working capital along with reduction in tax expense resulted in increased NOCFPS. (end)
The first part of this announcement is missing from the archive. - Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2022 to the respective shareholders.
- Category Change
The Company will be placed in 'A' category from existing 'N' category with effect from January 24, 2023 as the Company has reported disbursement of 11% Cash dividend for the year ended June 30, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 24, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2022.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.